{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:46:31Z","timestamp":1792511191833,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","award":["1281449"],"award-info":[{"award-number":["1281449"]}],"id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["Impact Grant"],"award-info":[{"award-number":["Impact Grant"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020951","name":"Fonds de recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["Program Project Grant"],"award-info":[{"award-number":["Program Project Grant"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["148373"],"award-info":[{"award-number":["148373"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PLL-185690"],"award-info":[{"award-number":["PLL-185690"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-190027"],"award-info":[{"award-number":["PJT-190027"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016328","name":"Fondation du cancer du sein du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000521","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103050","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:43:38Z","timestamp":1789137818000},"page":"103050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neutrophil elastase-mediated myoepithelial loss is a therapeutic vulnerability in ductal carcinoma in situ progression"],"prefix":"10.1016","volume":"7","author":[{"given":"Tarek","family":"Taifour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9line","family":"Mass\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5433-860X","authenticated-orcid":false,"given":"Xiwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse Dane","family":"Echavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Sanguin-Gendreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3615-4802","authenticated-orcid":false,"given":"Anne","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-1233","authenticated-orcid":false,"given":"Adda-Lee","family":"Graham-Paquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9726-7930","authenticated-orcid":false,"given":"Miranda","family":"Addie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Solymoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4596-3605","authenticated-orcid":false,"given":"Bin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Proud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Samer","family":"Attalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Jisoo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Papavasiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellen","family":"Kuasne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khandan","family":"Keyomarsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"McCaffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morag","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103050_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","article-title":"Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)","volume":"31","author":"Groen","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.xcrm.2026.103050_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","article-title":"Controversies in the Treatment of Ductal Carcinoma in Situ","volume":"68","author":"Barrio","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2026.103050_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/3617","article-title":"Role of myoepithelial cells in breast tumor progression","volume":"15","author":"Pandey","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.xcrm.2026.103050_bib4","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-19-2563","article-title":"Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma","volume":"26","author":"Pareja","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/modpathol.2017.21","article-title":"Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer","volume":"30","author":"Pang","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.xcrm.2026.103050_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajpath.2018.07.031","article-title":"Morphologic and Molecular Features of Breast Ductal Carcinoma in Situ","volume":"189","author":"Sanati","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.103050_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2026.103050_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.trecan.2023.01.002","article-title":"Everybody needs good neighbours: the progressive DCIS microenvironment","volume":"9","author":"Gibson","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2026.103050_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41467-017-02481-5","article-title":"Macrophages orchestrate breast cancer early dissemination and metastasis","volume":"9","author":"Linde","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103050_bib10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103050_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","article-title":"Regulation of in situ to invasive breast carcinoma transition","volume":"13","author":"Hu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103050_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","article-title":"Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma","volume":"185","author":"Risom","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103050_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103050_bib14","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1172\/JCI67484","article-title":"Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis","volume":"123","author":"Cools-Lartigue","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103050_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118699","article-title":"Tumor-associated neutrophils as new players in immunosuppressive process of the tumor microenvironment in breast cancer","volume":"264","author":"Hajizadeh","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.xcrm.2026.103050_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12885-021-07789-6","article-title":"Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy","volume":"21","author":"Geng","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2026.103050_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31557\/APJCP.2025.26.1.207","article-title":"The Role of Tumor-Associated Neutrophils in Early Luminal HER2-Negative Breast Cancer Progression","volume":"26","author":"Zakurdaev","year":"2025","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.xcrm.2026.103050_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/acsnanomed.5c00003","article-title":"Neutrophils: A Double-Edged Sword for Cancer Immunotherapy","volume":"1","author":"Zhang","year":"2026","journal-title":"ACS Nano Med."},{"key":"10.1016\/j.xcrm.2026.103050_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/983698","article-title":"Neutrophils in Cancer: Two Sides of the Same Coin","volume":"2015","author":"Uribe-Querol","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2159-8290.CD-17-0222","article-title":"Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition","volume":"7","author":"Gil Del Alcazar","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103050_bib21","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/bcr3603","article-title":"Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression","volume":"16","author":"Rao","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41388-020-01560-0","article-title":"Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo","volume":"40","author":"Attalla","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103050_bib23","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","article-title":"Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases","volume":"163","author":"Lin","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.103050_bib24","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","article-title":"The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer","volume":"56","author":"Taifour","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103050_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.199307","article-title":"The CHI3L1-Neutrophil Axis Drives Immune Suppression and Breast Cancer Metastatic Dissemination","volume":"11","author":"Taifour","year":"2026","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.103050_bib26","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.91.23.11236","article-title":"Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene","volume":"91","author":"Maroulakou","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103050_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1438s72","article-title":"Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes","volume":"72","author":"Usary","year":"2016","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103050_bib28","doi-asserted-by":"crossref","first-page":"25965","DOI":"10.1074\/jbc.M116.741884","article-title":"Identification of Neutrophil Exocytosis Inhibitors (Nexinhibs), Small Molecule Inhibitors of Neutrophil Exocytosis and Inflammation: DRUGGABILITY OF THE SMALL GTPase Rab27a","volume":"291","author":"Johnson","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2026.103050_bib29","series-title":"The Role of Neutrophil Extracellular Traps in Cancer Progression and Metastasis","author":"De Meo","year":"2022"},{"key":"10.1016\/j.xcrm.2026.103050_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpha.2022.12.003","article-title":"Neutrophil elastase: From mechanisms to therapeutic potential","volume":"13","author":"Zeng","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.xcrm.2026.103050_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12672-024-01010-3","article-title":"Targeting neutrophil elastase is a promising direction for future cancer treatment","volume":"15","author":"Jia","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.xcrm.2026.103050_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(99)00268-X","article-title":"Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043","volume":"374","author":"Fujie","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103050_bib33","first-page":"337","article-title":"The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer","volume":"63","author":"Foekens","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.111.182139","article-title":"AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase","volume":"339","author":"Stevens","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.xcrm.2026.103050_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1535-7163.MCT-23-0414","article-title":"Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis","volume":"23","author":"Lulla","year":"2024","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.xcrm.2026.103050_bib36","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.ajpath.2015.07.004","article-title":"Myoepithelial cell differentiation markers in ductal carcinoma in situ progression","volume":"185","author":"Russell","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.103050_bib37","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mc.23171","article-title":"Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition","volume":"59","author":"Mitchell","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.xcrm.2026.103050_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/bcr1286","article-title":"Myoepithelial cells: good fences make good neighbors","volume":"7","author":"Adriance","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2026.103050_bib40","article-title":"The molecular chronology of mammary epithelial cell fate switching","author":"Vallmajo-Martin","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.103050_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","article-title":"A Preclinical Model for ER\u03b1-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response","volume":"29","author":"Sflomos","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103050_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ccell.2023.04.002","article-title":"A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression","volume":"41","author":"Hutten","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103050_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13058-024-01927-1","article-title":"Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ","volume":"26","author":"Debeljak","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012100","article-title":"Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS)","volume":"5","author":"Toussaint","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103050_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7150\/ijbs.7.147","article-title":"The myoepithelial cell layer may serve as a potential trigger factor for different outcomes of stage-matched invasive lobular and ductal breast cancers","volume":"7","author":"Hsiao","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.xcrm.2026.103050_bib46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ccell.2026.03.015","article-title":"Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progression","volume":"44","author":"Bui","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103050_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2023.03.001","article-title":"An extracellular matrix stiffness-induced breast cancer cell transcriptome resembles the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)","volume":"654","author":"G\u00f6ransson","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103050_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1158\/1541-7786.MCR-20-0949","article-title":"Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System","volume":"19","author":"Trinh","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib49","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/2326-6066.CIR-21-0804","article-title":"Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer","volume":"10","author":"Gil Del Alcazar","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.103050_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-016-4036-0","article-title":"Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast","volume":"161","author":"Campbell","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.xcrm.2026.103050_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.breast.2022.04.004","article-title":"Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ","volume":"64","author":"Darvishian","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.xcrm.2026.103050_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10911-018-9409-z","article-title":"Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression","volume":"23","author":"Nelson","year":"2018","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.xcrm.2026.103050_bib53","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jleuko\/qiad004","article-title":"Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis","volume":"113","author":"Sheng","year":"2023","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.103050_bib54","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01019-2025","article-title":"Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency","volume":"66","author":"Wells","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2026.103050_bib55","first-page":"111","article-title":"A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium","volume":"9","author":"Vogelmeier","year":"2012","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.xcrm.2026.103050_bib56","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: A consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.103050_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1158\/2767-9764.CRC-23-0319","article-title":"Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1\u03b2\/CXCR2 Axis in Generation of Metastasis-specific Neutrophils","volume":"4","author":"Fetit","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103050_bib58","article-title":"Comparison of single-cell RNA-seq methods to enable transcriptome profiling of neutrophils in clinical samples","volume":"5","author":"Hatje","year":"2025","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xcrm.2026.103050_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092406","article-title":"Current Understanding of the Neutrophil Transcriptome in Health and Disease","volume":"10","author":"Garratt","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2026.103050_bib60","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.103050_bib61","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1073\/pnas.1003034107","article-title":"beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression","volume":"107","author":"Huck","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103050_bib62","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.celrep.2019.05.091","article-title":"Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis","volume":"27","author":"Hsu","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103050_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1096\/fj.01-0551com","article-title":"A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology","volume":"16","author":"Gunther","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.xcrm.2026.103050_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-3-030-20301-6_4","article-title":"Breast Cancer: Current Perspectives on the Disease Status","volume":"1152","author":"Fahad Ullah","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.xcrm.2026.103050_bib65","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/ijc.27841","article-title":"An international comparison of male and female breast cancer incidence rates","volume":"132","author":"Ly","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.103050_bib66","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/onc.2010.518","article-title":"Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes","volume":"30","author":"Tabari\u00e8s","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2026.103050_bib67","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1038\/s41467-024-53023-9","article-title":"Osteopontin is a therapeutic target that drives breast cancer recurrence","volume":"15","author":"Gu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103050_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.199927","article-title":"Activating mutations in ESR1 contribute to an immunosuppressive breast tumor microenvironment by dampening cytokine secretion","volume":"11","author":"Gu","year":"2026","journal-title":"JCI Insight"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:14:11Z","timestamp":1792509251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126004672"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103050","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil elastase-mediated myoepithelial loss is a therapeutic vulnerability in ductal carcinoma in situ progression","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103050"}}